+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Herpes Simplex Virus Treatment Market Size, Share & Industry Trends Analysis Report by Drug Type, Type, Distribution Channel, Country and Growth Forecast, 2022-2028

  • PDF Icon

    Report

  • 88 Pages
  • March 2023
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5778875
The Latin America, Middle East and Africa Herpes Simplex Virus Treatment Market should witness market growth of 6.6% CAGR during the forecast period (2022-2028).

As HSV infection is more likely to reactivate in the first few months following solid organ and bone marrow transplants, the rise in the number of transplant recipients is a factor in the market's expansion. In accordance with this, researchers are concentrating on creating novel antiviral drugs to increase the range of available treatments for genital and orolabial herpes. Also, they are bringing out antiviral creams or ointments that can lessen HSV-related itching, burning, or tingling sensations, enhance the quality of life (QoL) of patients, and stop infected persons from transmitting the virus.

Many people have HSV that is asymptomatic, which means they carry the virus but have never experienced a herpes outbreak or active episode. Others may occasionally get sores or blisters that are tiny and filled with fluid. These blisters can appear on the hands, fingers, or other body parts but typically on the genitalia, mouth, or lips. The herpes virus can be spread through sexual contact, but other ways exist. Herpes carries a lot of stigmas, yet the virus is fairly widespread. As more people are becoming aware of this, the demand for HSV medication is rising.

LatinAmerica has ahigh HSV-2 seroprevalence. An estimated 20% to 60% of people are infected. Middle-aged Colombian women were found to have the highest HSV-2 frequency in the region. In Brazil, women are more likely to contract HSV-2 if their male partners have a record of anal sex and have had numerous sexual partners during their lifetime. As a result, many regional governments have increased their efforts to mitigate the burden of the disease as well as increase the awareness about it among the general public. The government's provision of HSV treatment at affordable costs is among these efforts. Consequently, such efforts significantly boost the market expansion in this region.

The Brazil market dominated the LAMEA Herpes Simplex Virus Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $47.6 Million by 2028. The Argentina market is experiencing a CAGR of 7.2% during (2022-2028). Additionally, The UAE market would display a CAGR of 6.3% during (2022-2028).

Based on Drug Type, the market is segmented into Valacyclovir, Acyclovir, and Famciclovir. Based on Type, the market is segmented into Herpes simplex virus-1 Infection, and Herpes simplex virus-2 Infection. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Pfizer, Inc., Amneal Pharmaceuticals, Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., Glenmark Pharmaceuticals Limited, Fresenius SE & Co. KGaA, Novartis AG, Viatris, Inc., and Emcure Pharmaceuticals Limited.

Scope of the Study

By Drug Type

  • Valacyclovir
  • Acyclovir
  • Famciclovir

By Type

  • Herpes simplex virus-1 Infection
  • Herpes simplex virus-2 Infection

By Distribution Channel

  • Drug Store & Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Abbott Laboratories
  • Pfizer, Inc.
  • Amneal Pharmaceuticals, Inc.
  • GlaxoSmithKline PLC
  • Teva Pharmaceuticals Industries Ltd.
  • Glenmark Pharmaceuticals Limited
  • Fresenius SE & Co. KGaA
  • Novartis AG
  • Viatris, Inc.
  • Emcure Pharmaceuticals Limited

Unique Offerings

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Herpes Simplex Virus Treatment Market, by Drug Type
1.4.2 LAMEA Herpes Simplex Virus Treatment Market, by Type
1.4.3 LAMEA Herpes Simplex Virus Treatment Market, by Distribution Channel
1.4.4 LAMEA Herpes Simplex Virus Treatment Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Herpes Simplex Virus Treatment Market by Drug Type
3.1 LAMEA Valacyclovir Market by Country
3.2 LAMEA Acyclovir Market by Country
3.3 LAMEA Famciclovir Market by Country
Chapter 4. LAMEA Herpes Simplex Virus Treatment Market by Type
4.1 LAMEA Herpes simplex virus-1 Infection Market by Country
4.2 LAMEA Herpes simplex virus-2 Infection Market by Country
Chapter 5. LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel
5.1 LAMEA Drug Store & Retail Pharmacies Market by Country
5.2 LAMEA Hospital Pharmacies Market by Country
5.3 LAMEA Online Pharmacies Market by Country
Chapter 6. LAMEA Herpes Simplex Virus Treatment Market by Country
6.1 Brazil Herpes Simplex Virus Treatment Market
6.1.1 Brazil Herpes Simplex Virus Treatment Market by Drug Type
6.1.2 Brazil Herpes Simplex Virus Treatment Market by Type
6.1.3 Brazil Herpes Simplex Virus Treatment Market by Distribution Channel
6.2 Argentina Herpes Simplex Virus Treatment Market
6.2.1 Argentina Herpes Simplex Virus Treatment Market by Drug Type
6.2.2 Argentina Herpes Simplex Virus Treatment Market by Type
6.2.3 Argentina Herpes Simplex Virus Treatment Market by Distribution Channel
6.3 UAE Herpes Simplex Virus Treatment Market
6.3.1 UAE Herpes Simplex Virus Treatment Market by Drug Type
6.3.2 UAE Herpes Simplex Virus Treatment Market by Type
6.3.3 UAE Herpes Simplex Virus Treatment Market by Distribution Channel
6.4 Saudi Arabia Herpes Simplex Virus Treatment Market
6.4.1 Saudi Arabia Herpes Simplex Virus Treatment Market by Drug Type
6.4.2 Saudi Arabia Herpes Simplex Virus Treatment Market by Type
6.4.3 Saudi Arabia Herpes Simplex Virus Treatment Market by Distribution Channel
6.5 South Africa Herpes Simplex Virus Treatment Market
6.5.1 South Africa Herpes Simplex Virus Treatment Market by Drug Type
6.5.2 South Africa Herpes Simplex Virus Treatment Market by Type
6.5.3 South Africa Herpes Simplex Virus Treatment Market by Distribution Channel
6.6 Nigeria Herpes Simplex Virus Treatment Market
6.6.1 Nigeria Herpes Simplex Virus Treatment Market by Drug Type
6.6.2 Nigeria Herpes Simplex Virus Treatment Market by Type
6.6.3 Nigeria Herpes Simplex Virus Treatment Market by Distribution Channel
6.7 Rest of LAMEA Herpes Simplex Virus Treatment Market
6.7.1 Rest of LAMEA Herpes Simplex Virus Treatment Market by Drug Type
6.7.2 Rest of LAMEA Herpes Simplex Virus Treatment Market by Type
6.7.3 Rest of LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Pfizer, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional & Segmental Analysis
7.2.4 Research & Development Expense
7.2.5 Recent Strategies and Developments
7.2.5.1 Partnerships, Collaborations, and Agreements
7.3 Amneal Pharmaceuticals, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent Strategies and Developments
7.3.5.1 Approvals and Trials
7.4 GlaxoSmithKline PLC (GSK)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent Strategies and Developments
7.4.5.1 Approvals and Trials
7.5 Teva Pharmaceutical Industries Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Glenmark Pharmaceuticals Limited
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Fresenius SE & Co. KGaA
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.8 Novartis AG
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Viatris, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental Analysis
7.9.4 Research & Development Expense
7.10. Emcure Pharmaceuticals Limited
7.10.1 Company Overview

Companies Mentioned

  • Abbott Laboratories
  • Pfizer, Inc.
  • Amneal Pharmaceuticals, Inc.
  • GlaxoSmithKline PLC
  • Teva Pharmaceuticals Industries Ltd.
  • Glenmark Pharmaceuticals Limited
  • Fresenius SE & Co. KGaA
  • Novartis AG
  • Viatris, Inc.
  • Emcure Pharmaceuticals Limited

Methodology

Loading
LOADING...